Our vision is a future where individuals living with GABA-A Variants experience improved quality of life and have access to personalized treatments. We envision a world where repurposed FDA-approved drugs and gene therapies offer hope and relief to patients, effectively managing symptoms and addressing the underlying genetic causes of GABA-A Variants.